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Hepatitis C virus (HCV) encodes two glycoproteins, E1 and E2, that interact to form both native and aggregated complexes
in tissue culture cells. In native complexes, E1 and E2 are associated by noncovalent interactions and such complexes are
considered to constitute the authentic interactions between the proteins. By contrast, the proteins are linked by covalent,
disulfide bonds in aggregated complexes. From studies with a mutant in which cysteine residues in E1 have been substituted
with other amino acids, we show that E1 continues to associate with E2, although the migratory patterns of the proteins on
gels are consistent with the formation of aggregated complexes. Therefore, such complexes can be stabilized by noncovalent
as well as covalent interactions. To further examine the requirements for native complex formation, segments of foreign
glycoproteins were linked to regions of E2. Our data provide direct evidence for the requirement of C-terminal sequences in
E2 that contain the transmembrane domain to permit oxidation of E1 and assembly of a native complex. By contrast, native
complexes and oxidized E1 are not found in the presence of chimeric proteins containing the E2 ectodomain. These data
suggest that interaction of E1 with the E2 transmembrane domain is critical for native complex formation. © 2001
Academic Press
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EINTRODUCTION
Hepatitis C virus (HCV) encodes two glycoproteins, E1
and E2, which are thought to constitute the envelope of
the virus (Houghton, 1996). It is well established that E1
and E2 associate and two types of complex have been
identified (Grakoui et al., 1993; Ralston et al., 1993; Ma-
tsuura et al., 1994; Selby et al., 1994). In one complex,
ermed the native form, the proteins interact through
oncovalent, intermolecular interactions. The second
omplex is considered to form through aggregation of
ncorrectly folded glycoproteins that associate by cova-
ent, disulfide links. In a recent study using dithiothreitol
DTT) in situ to disrupt disulfide bonds, we showed that
1 and E2 in aggregated complexes could be connected
lso by noncovalent interactions (Patel et al., 1999). The
ontribution of either complex to virion formation is not
nown, although it is considered that native complexes
ontain authentic interactions between the glycopro-
eins.
Conformational antibodies (Deleersnyder et al., 1997;
uvet et al., 1998) and sedimentation on density gradi-
nts (Ralston et al., 1993; Dubuisson and Rice, 1996;
oung et al., 1998) were previously employed to distin-
uish between both types of complex. In addition, migra-
ion under nonreducing, denaturing conditions on poly-1 To whom correspondence and reprint requests should be ad-
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58crylamide gels was used to identify the complexes that
ccumulate in cells (Ralston et al., 1993; Dubuisson and
ice, 1996; Patel et al., 1999). Such studies revealed that
1 and E2 from native complexes migrate as monomers,
hereas the proteins in aggregated complexes barely
nter the resolving component of gels. The native com-
lex forms more slowly than the aggregated form and
his is accompanied by the appearance of E1 in an
xidized state (Dubuisson and Rice, 1996). Since oxida-
ion of E2 precedes that of E1, it has been suggested that
2 is required for correct folding of E1 (Dubuisson and
ice, 1996; Michalak et al., 1997).
E1 and E2 cannot be detected on the cell surface and
re retained within the endoplasmic reticulum (ER) (Ral-
ton et al., 1993; Selby et al., 1994; Dubuisson and Rice,
996; Cocquerel et al., 1998). For both proteins, there is
o evidence for cycling between the Golgi apparatus and
R (Duvet et al., 1998; Cocquerel et al., 1999) and hence
ER localization is consistent with a retention mechanism
rather than a process of retrieval from post-ER compart-
ments. Retention is mediated by hydrophobic, transmem-
brane sequences present at the C termini of the proteins
(Cocquerel et al., 1998, 1999; Flint and McKeating, 1999).
In the case of E2, replacement of the transmembrane
region with the corresponding domains from proteins
normally transported to the cell surface can direct E2 to
the plasma membrane (Cocquerel et al., 1998; Lagging et
al., 1998). Hence, retention in the ER is not solely a
consequence of aberrant E2 folding. The transmembrane
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59ROLE OF HCV E2 TRANSMEMBRANE DOMAINdomains also function as signal sequences to direct
cleavage from the adjacent gene product and single-site
mutations in the transmembrane sequences are suffi-
cient to either reduce or abolish signal peptide function
(Cocquerel et al., 2000). Finally, there is evidence that
removal or mutation of the transmembrane domains in-
hibits formation of native complexes between E1 and E2
(Selby et al., 1994; Michalak et al., 1997; Cocquerel et al.,
1998, 2000). Controversially, other reports previously
showed that the ectodomains of E1 and E2 alone are
sufficient for interaction between the proteins (Matsuura
et al., 1994; Hussy et al., 1997; Yi et al., 1997), although
hese could represent aggregated complexes (Michalak
t al., 1997).
Oxidation of E1 is impaired in the absence of E2,
eading to the suggestion that E2 performs a “chaperone-
ike” function (Dubuisson and Rice, 1996; Michalak et al.,
997). In this report, we extended these studies by com-
aring the properties of E1 in the presence and absence
f E2, to establish criteria for assessing the conforma-
ional status of E1. Since disulfide bonds have been
mplicated in complexes formed by the HCV glycopro-
eins and are necessary for E1 oxidation, the ability of a
utant form of E1 that lacks cysteine residues to asso-
iate with E2 and form a native complex was examined.
inally, we directly tested whether the ecto- or trans-
embrane domains of E2 are sufficient for native com-
lex formation by fusion with segments from foreign
lycoproteins of viral origin.
RESULTS
ehavior of HCV E1 in the presence and absence
f E2
In a previous report, it was shown that generation of
n oxidized, monomeric form of E1 is dependent on the
resence of E2 (Michalak et al., 1997). Using the Semliki
orest virus (SFV) system to express the HCV glycopro-
eins in baby hamster kidney (BHK) cells, we reexamined
his phenomenon. After electroporation with RNA from
wo constructs, pSFV/E1 and pSFV/E1E2p7 (Fig. 1A),
ells were radiolabeled and immunoprecipitations were
erformed on the resultant cell extracts using an E1-
pecific monoclonal antibody (MAb), AP21.010. Under
onreducing electrophoresis conditions, E1 and E2 were
etected following immunoprecipitation with the extract
rom pSFV/E1E2p7-electroporated cells, indicating that
hey formed a native complex (Fig. 2A, lane 2). E1 mi-
rated as a single species, whereas E2 was more dif-
use. Western blot analysis using an E2-specific MAb
onfirmed the presence of E2 in the immunoprecipitated
aterial (Fig. 2B, lane 2). The diffuse nature of E2 prob-
bly results from glycosylation of the protein, although
he material may also contain both E2 and E2-p7 species
s a result of the incomplete cleavage at the processing
ite between E2 and p7. This phenomenon was reportedreviously (Dubuisson et al., 1994). For simplicity, the
iffuse material will be referred to only as E2.
By contrast to the E1 species detected in the pSFV/
1E2p7 sample, E1 immunoprecipitated from the
SFV/E1 cell extract appeared as a series of regularly
paced bands, none of which comigrated with E1 from
he pSFV/E1E2p7 sample (Fig. 2A, lane 1); upon endo H
igestion of the pSFV/E1 sample, only a single E1 spe-
ies was observed, indicating that the bands represent
ifferentially glycosylated forms of the protein (data not
hown). Examination of the samples under reducing con-
itions showed that the major E1 species from pSFV/
1E2p7 and pSFV/E1 cell extracts comigrated (Fig. 2C,
anes 1 and 2). Hence, the distinct mobilities in the
onreducing polyacrylamide gel were a consequence of
ifferent oxidation states of the protein in the presence
nd absence of E2. In addition, a series of bands of
esser mobility than E1, none of which comigrated with
2, were observed only with the pSFV/E1 sample in the
educing gel (Fig. 2C, lanes 1 and 2); these could be
etected by Western blot analysis using an E1-specific
ntiserum (data not shown). Based on their apparent
olecular weights, the species of .50 kDa match the
redicted sizes of dimers, trimers, etc., of E1. Therefore,
t was concluded that the higher-molecular-weight pro-
eins represent oligomeric forms of E1. The oligomers
resumably arise from disruption by the reducing agent
f the aggregated material, which barely enters the re-
olving component of the nonreducing gel (Fig. 2A).
ence, disulfide links exist between E1 molecules in the
ggregate; however, the appearance of oligomeric forms
nder reducing, denaturing conditions indicates that
trong noncovalent intermolecular interactions also oc-
ur.
To further address the oxidation state of E1 produced
n the presence of E2 and the role of disulfide bonds in
he formation of E1 oligomers, two plasmids, pSFV/E12cys
and pSFV/E12cysE2p7 expressing E1 alone and linked to
E2, respectively, were made in which all eight of the
cysteine residues in E1 had been altered to serine or
alanine (Fig. 3A). The cysteine residue at position 207
was substituted with an alanine, since introduction of a
serine at this position would create a novel predicted
glycosylation site in E1. Apart from the cysteine substi-
tutions, pSFV/E12cys and pSFV/E12cysE2p7 were identical
to pSFV/E1 and pSFV/E1E2p7, respectively (Fig. 1A). Ra-
diolabeled proteins from cell extracts electroporated
with RNA from these constructs were assayed by immu-
noprecipitation with anti-E1 antiserum R528 and precip-
itated material analyzed by polyacrylamide gel electro-
phoresis. Under nonreducing conditions, the monomeric
forms of cys2 E1 protein generated by either of these
constructs comigrated with the E1 species made in the
absence of E2 but not with E1 synthesized in the pres-
ence of E2 (Fig. 3B; compare lanes 2 and 3 with lanes 1
and 4). Since cys2 E1 protein cannot form intramolecular
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60 PATEL, PATEL, AND MCLAUCHLANdisulfide bonds, this confirms that E1 associated with E2
in a native complex is in an oxidized state. Interestingly,
a reduction in the amount of monomeric E2 that copre-
cipitated with the cys2 E1 protein as compared to the
wild-type form of the protein was evident in the nonre-
ducing gel, although comparable amounts of E2 were
present on reduction of the samples (compare Figs. 3B
and 3C, lanes 1 and 2). Similar data were obtained when
proteins were immunoprecipitated with the anti-E2 MAb
ALP98 (Figs. 3D and 3E, lanes 1 and 2). Thus, removal of
the cysteine residues in E1 does not prevent complex
FIG. 1. (A) Schematic of SFV constructs. In all constructs except for p
consisting of residues 1–65 linked to residues 169–191 that were use
C-terminal amino acid in constructs pSFV/E1E2p7 and pSFV/E2p7 was
these plasmids contained the N-terminal region of NS2 as well as thos
E1 transmembrane domain was used to initiate translation in plas
pSFV/E1E2702 were residues 387 and 702, respectively, which were imm
HSV-1 gD and rubella virus (RV) E1 transmembrane/cytoplasmic seq
predicted ectodomain of HSV-1 gD (amino acid residues 11–312; McGeo
pSFV/E1gDE2TM, and pSFV/E1gDRVE1TM. The positions of cleavage sites th
at the junctions of chimeric proteins. Sequences are shown for: (i) the ju
gD (beginning at residue 11) in plasmids pSFV/E1gD, pSFV/E1gDE2TM, an
of HSV-1 gD (ending at residue 312) and residues 703–758 of the H
ectodomain and p7 sequences; (iii) the junction between the ectodom
sequences of HSV-1 gD (residues 316–370) in pSFV/E1E2gDTM; and (iv)
the transmembrane/cytoplasmic sequences of rubella virus E1 (Hobm
boxes and the predicted transmembrane regions for HCV E2, HSV-1 gD
(i) and E2/p7 (ii) are arrowed.formation with E2, although there is an increase in the
amount of E2 in such complexes that is in the form of anaggregate. We also noted in the nonreducing gel that
oligomeric forms of cys2 E1 were generated in the ab-
ence of E2 (Fig. 3B, lane 3). Oligomers continued to
xist under reducing conditions, indicating that intermo-
ecular disulfide bond formation is not essential for oli-
omerization, although the abundance of these products
as reduced compared with that of wild-type E1 protein
Fig. 3C, lanes 3 and 4). This could result from reduced
ggregation because of the inability of cys2 E1 protein to
form intermolecular disulfide bonds. In addition, oli-
gomers identified for cys2 E1 were slightly larger in size
p7, the HCV E1 sequences were preceded by a segment of HCV core
ect translocation and correct processing of E1 and E2 in the ER. The
sidue 837, which was immediately followed by a stop codon; therefore,
e glycoproteins and p7. The methionine residue at position 345 in the
FV/E2p7. The C termini of the coding sequences in pSFV/E1 and
y followed by a stop codon. In pSFV/E1E2gDTM and pSFV/E1E2RVE1TM, the
were linked to residues 702 and 701, respectively, of HCV E2. The
l., 1988) was linked directly to HCV residue 387 in plasmids pSFV/E1gD,
erate the mature HCV proteins are arrowed. (B) Amino acid sequences
between HCV E2 (ending at residue 387) and the ectodomain of HSV-1
/E1gDRVE1TM; (ii) the junction in pSFV/E1gDE2TM between the ectodomain
lyprotein that contain the E2 transmembrane domain flanked by E2
HCV E2 (ending at residue 702) and the transmembrane/cytoplasmic
ction between the ectodomain of HCV E2 (ending at residue 701) and
l., 1997). The HSV-1 and rubella virus residues are shown in shaded
bella virus E1 are underlined. The cleavage sites between HCV E1/E2SFV/E2
d to dir
HCV re
e of th
mid pS
ediatel
uences
ch et a
at gen
nction
d pSFV
CV po
ain of
the jun
an et athan those produced by wild-type protein (Fig. 3C, lanes
3 and 4). The size differences probably result from dif-
61ROLE OF HCV E2 TRANSMEMBRANE DOMAINferential glycosylation of E1 in the oligomers since the
endo H-digested oligomers of wild-type and cys2 E1
comigrated (data not shown). The above-noted data in
relation to E1 oxidation and oligomerization were repro-
ducible over several experiments and therefore establish
criteria to assess the behavior of E1 in the presence and
absence of E2.
The ectodomain of E2 is not sufficient to prevent
oligomerization of E1
The C-terminal hydrophobic sequences of E2 that con-
tain the transmembrane domain were previously impli-
cated in complex formation (Selby et al., 1994; Michalak
et al., 1997; Cocquerel et al., 1998, 2000), although other
reports suggest that the ectodomain contributes to
E1–E2 association (Matsuura et al., 1994; Hussy et al.,
1997; Yi et al., 1997). Therefore, we analyzed the behavior
of E1 expressed along with E2 truncated at residue 702
and which, therefore, lacks E2 transmembrane domain
sequences (Fig. 1A). Immunoprecipitations with the E2-
specific MAb ALP98 revealed that oxidized E1 was
present under nonreducing electrophoretic conditions
on expression with full-length E2 but not with the trun-
FIG. 2. Oxidation state of E1 expressed in the presence and absence
of E2. Cells were electroporated with pSFV/E1E2p7 and pSFV/E1 RNAs
and radiolabeled between 4.5 and 16 h after electroporation. After
harvesting, immunoprecipitations were performed on the crude ex-
tracts with E1-specific MAb AP21.010. Eluted material was analyzed
under nonreducing (A and B) and reducing (C) electrophoresis condi-
tions. In (A) and (C), lane 1 shows precipitated material derived from
cells electroporated with pSFV/E1 RNA and lane 2 contains precipi-
tates from cells electroporated with pSFV/E1E2p7 RNA. (B) Western
blot analysis using anti-E2 MAb ALP98 of the immunoprecipitated
samples shown in (A) and (C). The positions of aggregated material
(Agg), oxidized (ox), and reduced (red) E1 and E2 and oxidized, un-
cleaved E1E2 protein are indicated. Oligomers of E1 (x2, x3, etc.) also
are shown.cated form of the protein (Fig. 4A, lanes 1 and 2). How-
ever, in a reducing gel, E1 could be detected along withtruncated E2 (Fig. 4A, lanes 4 and 5). This indicates that
E1–E2 interactions, which generate native complexes,
are reduced to undetectable levels on removal of se-
quences containing the E2 transmembrane segment.
From a corresponding set of immunoprecipitations
with the E1-specific antibody AP21.010, E1 made in the
presence of truncated E2 gave a pattern of oligomeriza-
tion on reducing gels which was identical to that found
with E1 expressed alone (Fig. 4B, lanes 4 and 6). The
dimeric form of E1 has a very similar apparent molecular
weight to the truncated form of E2. Western blot analysis
confirmed that the band representing dimers of E1 in Fig.
4B (lane 6) also contained truncated E2 (data not shown).
Thus, as well as forming oligomers, some E1 could
associate with truncated E2 as was observed with im-
munoprecipitations using the E2 MAb (Fig. 4A, lane 5). By
contrast, E1 expressed along with full-length E2 showed
no evidence of oligomers (Fig. 4B, lane 5). Under nonre-
ducing conditions, monomeric E1 protein expressed in
the presence of truncated E2 could be detected but it
gave a complex pattern that was a combination of re-
duced and oxidized forms (Fig. 4B; compare lane 3 with
lanes 1 and 2). We conclude that on expression with a
truncated form of E2 that lacks the transmembrane do-
main, the majority of E1 exists in an aggregated state
and only a small proportion can achieve an oxidized
conformation.
The E2 transmembrane domain fused to the
ectodomain of a heterologous glycoprotein allows E1
oxidation and prevents homo-oligomerization
In light of the above results, we tested whether the E2
transmembrane domain could affect the behavior of E1. A
series of chimeric constructs were created in which the
ecto- and transmembrane domains of E2 were substi-
tuted with corresponding regions of the herpes simplex
virus type 1 (HSV-1) gD glycoprotein, an envelope com-
ponent of virions (Figs. 1A and 1B) (McGeoch et al.,
1988). In addition, we used the transmembrane/cytoplas-
mic domain from rubella virus E1, a known ER retention
signal (Hobman et al., 1997), to replace the region con-
taining the transmembrane domain in E2 for additional
control experiments (Figs. 1A and 1B). In immunolocal-
ization studies, we found that wild-type E2 could not be
detected on the cell surface, in agreement with previous
findings (data not shown) (Cocquerel et al., 1998). Linking
either the rubella virus E1 or HSV-1 gD transmembrane/
cytoplasmic domains to the E2 ectodomain directed
barely detectable amounts of E2 to the cell surface and
only small quantities of the E2 chimeras were resistant to
endo H digestion (data not shown).
Based on these assays, we concluded that the bulk of
the chimeric proteins containing the E2 ectodomain re-
main in the ER. Cells electroporated with RNA from a
construct encoding a polyprotein consisting of HCV E1
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62 PATEL, PATEL, AND MCLAUCHLANlinked to the HSV-1 gD coding sequences showed sur-
face expression of the HSV-1 glycoprotein but not E1
(Fig. 5A, panels i and v); permeabilization of cells, how-
ever, did reveal intracellular E1 protein (Fig. 5A, panel vi).
Replacing the transmembrane and cytoplasmic regions
of gD with a segment containing the transmembrane
domain of E2 (gDE2TM protein; Figs. 1A and 1B) dramati-
ally reduced the abundance of gD at the plasma mem-
rane, with barely detectable amounts of protein ob-
erved at the cell surface (Fig. 5A, panel iii). From West-
ern blot analysis, two gD species could be detected in
pSFV/E1gD cell extracts (labeled in Fig. 5B, lane 4) that
were indistinguishable in size from the products found in
HSV-1-infected cells (data not shown). Therefore, we
assume that gD is produced by proteolytic processing
from the E1-gD polyprotein by cleavage at the end of the
E1 sequences and is posttranslationally modified to give
proteins that are normally generated during HSV-1 infec-
tion. The higher-molecular-weight product, representing
the mature form of the protein that is both N- and O-
glycosylated (labeled F in Fig. 5B, lane 4) (Cohen et al.,
FIG. 3. The effect of substituting cysteine residues in E1 on comple
bars indicate the positions of cysteine residues in E1 and the shaded
electroporated with RNA derived from pSFV/E1E2p7 (lanes 1), pSFV/E1
4, (B) and (C) only]. After cells were radiolabeled, crude extracts were
and the E2 MAb, ALP98 (D and E). Precipitates were analyzed under
Positions of the aggregated material (Agg), oxidized (ox), and reduced1983; Johnson and Spear, 1983; Matthews et al., 1983;
Serafini et al., 1988), was resistant to endo H digestion
c
w(Fig. 5B, lane 5). By contrast, the lower-molecular-weight
product (labeled E in Fig. 5B, lane 4), indicative of gly-
cosylated but immature gD, was partially sensitive (Fig.
5B, lane 5). Only one major species was detected for
gDE2TM protein which was sensitive to endo H digestion
(Fig. 5B, lanes 1 and 2). Treatment with PNGase F also
showed that glycosidase-digested gD was of higher mo-
lecular weight than gDE2TM (Fig. 5B, lanes 3 and 6). Since
O-glycosylation of gD occurs in the Golgi apparatus
(Johnson and Spear, 1983) and the transmembrane seg-
ment of E2 is only slightly shorter than the transmem-
brane/cytoplasmic sequences of gD (Fig. 1B), we as-
sume that the lower molecular weight for gDE2TM primarily
results from lack of O-glycosylation. Hence, in agree-
ment with other studies (Cocquerel et al., 1998; Duvet et
l., 1998), our immunofluorescence and glycosidase di-
estion data demonstrate that the segment containing
he E2 transmembrane domain is sufficient to retain in
he ER a foreign glycoprotein that normally exits the
rganelle.
To examine the behavior of E1 on expression with the
tion. (A) Location and substitution of cysteine residues in E1. Vertical
presents the transmembrane domain of the protein. (B–E) Cells were
7 (lanes 2), pSFV/E12cys [lanes 3, (B) and (C) only], and pSFV/E1 [lanes
ed to immunoprecipitation with E1-specific antiserum, R528 (B and C)
ucing (B and D) and reducing (C and E) electrophoresis conditions.
rms of E1 and E2, and oligomeric forms of E1 (x2, x3, etc.) are shown.x forma
area re
2cysE2p
subjecthimeric proteins, immunoprecipitations were performed
ith antibodies specific for E2, gD, and E1. Immunopre-
[
c
E
63ROLE OF HCV E2 TRANSMEMBRANE DOMAINcipitation with anti-E2 MAb ALP98 revealed that oxidized
E1 was not associated with the E2 ectodomain linked to
either gD or rubella virus transmembrane/cytoplasmic
sequences (Fig. 6A, lanes 1–3). Under reducing condi-
tions, small quantities of E1 could be detected that had
interacted with the E2 chimeras (Fig. 6A, lanes 7 and 8).
Similar results were obtained with HCV E1 and HSV-1 gD
proteins generated from the E1-gD polyprotein using the
gD antibody 4846 (Fig. 6A, lanes 5 and 10), suggesting
that there may be some nonspecific interaction between
the HCV and HSV-1 proteins. Notably, an oxidized form of
E1 was efficiently coprecipitated by the gD antibody
along with oxidized gDE2TM protein (Fig. 6A, lane 4). From
immunoprecipitations with an E1-specific antiserum
R528, the E1 species precipitated from the pSFV/
E1gDE2TM cell extract was indicative of an oxidized con-
formation, although it did not precisely comigrate with
the oxidized form of E1 synthesized in the presence of E2
(Fig. 6B, lanes 2 and 3). A slight difference in the mobil-
ities of E1 expressed with E2 and gDE2TM proteins also is
evident in Fig. 6A (compare lanes 1 and 4). This may
FIG. 4. Examination of complex formation between E1 and truncated
E2 protein. Cells were electroporated with RNA and radiolabeled.
Crude extracts derived from these cells were subjected to immunopre-
cipitation with the E2-specific MAb, ALP98 (A) and E1-specific MAb,
AP21.010 (B). Precipitated material was analyzed under nonreducing
(lanes 1–3) and reducing (lanes 4–6) electrophoresis conditions. Sam-
ples were pSFV/E1E2p7 [lanes 1 and 4 in (A), lanes 2 and 5 in (B)],
pSFV/E1E2702 [lanes 2 and 5 in (A), lanes 3 and 6 in (B)], pSFV/E2p7
lanes 3 and 6 in (A)], and pSFV/E1 [lanes 1 and 4 in (B)]. The bands
orresponding to aggregated material (Agg), E2, truncated E2 (E2702),
1, and E1 oligomers are indicated.suggest subtle changes to the folding of E1 in the pres-
ence of the chimeric protein. Under reducing conditions,we did observe greater heterogeneity in the size of E1
species produced by pSFV/E1gDE2TM (Figs. 6A and 6B,
lane 9).
A similar phenomenon was found with E1 made by
other constructs (Fig. 6B, lanes 10–12) and may indicate
altered glycosylation or modification to E1. Again, this
may account for the differences in mobility found under
nonreducing conditions for oxidized E1 produced by
pSFV/E1E2p7 and pSFV/E1gDE2TM. As was the case with
the gD antibody, gDE2TM did coprecipitate with E1 using
anti-E1 antiserum R528 and could be detected under
both reducing and nonreducing conditions (Fig. 6B, lanes
3 and 9). In construct pSFV/E1gDE2TM, there are 13 resi-
dues of p7 downstream from the E2 transmembrane
segment that were included to allow processing at the
E2/p7 cleavage site, which normally occurs during mat-
uration of the proteins (Fig. 1B). Since processing at this
site may not be 100% efficient, it is possible that some of
the gDE2TM protein contains p7 residues that may contrib-
ute to E1 folding. To address this possibility, another
construct was made that was identical to pSFV/E1gDE2TM,
except that it lacked the p7 sequences; results with this
construct were identical to those shown for pSFV/
E1gDE2TM in Fig. 6 (data not shown). Therefore, E1 can
efficiently form a complex with a chimeric protein that
contains only HCV E2 residues 703–745, which encom-
pass the transmembrane domain, and the E1 protein in
such complexes is oxidized. Further data with the anti-E1
antiserum revealed that only faint quantities of E1 were
detected with the chimeras containing the E2 ectodo-
main under nonreducing conditions and there was no
evidence of chimeric forms of E2 (Fig. 6B, lanes 4–6). On
a reducing gel, oligomeric forms of E1 were apparent on
expression with the E2 ectodomain chimeric proteins
and gD (Fig. 6B; compare lanes 10–12 with lane 7). Under
these conditions, we did note the appearance of bands
corresponding in size to the chimeric proteins containing
the ectodomain of E2 (indicated as n and h in Fig. 6B,
lanes 10 and 11). This again suggests that, although the
E2 ectodomain can associate with E1, the resultant com-
plexes represent aggregates. By contrast, no oligomers
of E1 were found with the gD ectodomain linked to the E2
transmembrane segment (Fig. 6B, lane 9), further indi-
cating that E1 aggregates to a far lesser extent in the
presence of this chimeric protein.
To verify that oxidation and lack of aggregation of E1
were a direct consequence of the presence of the E2
transmembrane segment, the behavior of E1 was ex-
amined using another construct which was identical to
pSFV/E1gDE2TM, except that the gD ectodomain was
linked to the transmembrane/cytoplasmic sequences
of the rubella virus E1 glycoprotein (Fig. 1A). In immu-
nolocalization studies, the gD/RVE1 chimera was not
present on the surface of expressing cells and had a
distribution coincident with that of E1 (data not
fcosyla
64 PATEL, PATEL, AND MCLAUCHLANshown). We found that HCV E1, expressed from this
construct, gave a pattern of bands identical to that for
E1 expressed alone on examination under nonreduc-
ing electrophoretic conditions (Fig. 7; compare lane 2
with lanes 1 and 3). Although some oxidized E1 may be
present in these species, the similarities in the E1
patterns for the pSFV/E1gDRVE1TM and pSFV/E1 samples
suggest that most of E1 produced by pSFV/E1gDRVE1TM
does not contain intramolecular covalent bonds. More-
over, oligomers of E1 were detected in reducing gels
for pSFV/E1gDRVE1TM (Fig. 7, lane 5). These data confirm
that the E2 transmembrane segment has a critical role
FIG. 5. Intracellular localization of E1, gD, and gDE2TM proteins. (A) Im
ixed 12 h after electroporation with paraformaldehyde (PFA; panels i, ii
were processed for indirect immunofluorescence using HSV-1 gD-s
Constructs from which RNA was synthesized were pSFV/E1gD (pane
sensitivity of HSV-1 gD proteins. Cells were lysed 12 h postelectroporat
F. Following electrophoresis under reducing conditions, Western b
pSFV/E1gDE2TM (lanes 1–3) and pSFV/E1gD (lanes 4–6). Positions of gly
and immature forms (E) of gD referred to in the text are labeled.in the folding of E1, which is not simply a result of its
ER retention properties.DISCUSSION
Our studies further characterized the properties of the
HCV E1 glycoprotein by comparing its behavior in the
presence and absence of E2. In the absence of E2, E1
forms aggregates that are disrupted by reducing agents,
to generate multimeric forms of the protein that can be
identified upon gel electrophoresis. The existence of
oligomers under reducing conditions indicates that non-
covalent, intermolecular interactions can occur between
E1 molecules. Covalent interactions also appear to con-
tribute to E1–E1 association since the abundance of
calization of proteins. Cells electroporated with RNA transcripts were
vii) or PFA containing 0.1% Triton X-100 (panels ii, iv, vi, and viii). Cells
MAb 4846 (panels i–iv) and anti-E1 antiserum R528 (panels v–viii).
v, and vi) and pSFV/E1gDE2TM (panels iii, iv, vii, and viii). (B) Endo H
portions of the crude extracts were treated with endo H and PNGase
lysis was performed using gD-specific MAb 4846. Samples were
ted and deglycosylated forms of gD proteins are indicated. Mature (F)munolo
i, v, and
pecific
ls i, ii,
ion and
lot anaoligomers composed of E1 protein lacking any cysteine
residues is reduced. Thus, the interactions between E1
a65ROLE OF HCV E2 TRANSMEMBRANE DOMAINproteins may be covalent or noncovalent or, indeed, a
combination of both. By comparing the migratory pat-
terns of native E1 and a mutant form that lacks cysteine
residues, we also found that monomeric E1 synthesized
in the absence of E2 remained in a reduced state. This
contrasts with E1 made in the presence of E2, wherein
intramolecular disulfide bonds form and an oxidized
state is attained. These data confirm previous observa-
tions on the requirement of E2 for intramolecular disul-
fide bond formation within individual E1 molecules
(Michalak et al., 1997). The appearance of oxidized E1
and native E1–E2 complexes coincide and thus it is
assumed that such forms of E1 are correctly folded
(Dubuisson and Rice, 1996; Deleersnyder et al., 1997;
Michalak et al., 1997). The behavior of the HCV glyco-
FIG. 6. Examination of complex formation by chimeric E2 and gD
proteins with E1. Cells, electroporated with RNA, were radiolabeled.
Following cell lysis, crude extracts were subjected to immunoprecipi-
tation using E2-specific MAb ALP98 (lanes 1–3 and 6–8) and gD-
specific MAb 4846 (lanes 4, 5, 9, and 10) in (A). In (B), immunoprecipi-
tations were performed with E1 antiserum R528. Precipitated material
was examined under nonreducing [lanes 1–5 in (A), lanes 1–6 in (B)]
and reducing [lanes 6–10 in (A), lanes 7–12 in (B)] electrophoresis
conditions. Samples in (A) were derived from pSFV/E1E2p7 (lanes 1
and 6), pSFV/E1E2gDTM (lanes 2 and 7), pSFV/E1E2RVE1TM (lanes 3 and 8),
pSFV/E1gDE2TM (lanes 4 and 9), and pSFV/E1gD (lanes 5 and 10). In (B),
samples were derived from pSFV/E1 (lanes 1 and 7), pSFV/E1E2p7
(lanes 2 and 8), pSFV/E1gDE2TM (lanes 3 and 9), pSFV/E1E2gDTM (lanes 4
and 10), pSFV/E1E2RVE1TM (lanes 5 and 11), and pSFV/E1gD (lanes 6 and
12). The bands corresponding to aggregated material (Agg), oxidized
and reduced forms of E1, E2, and gD, and E1 oligomers are indicated.
Uncleaved E1-gDE2TM polyprotein (F) and mature gDE2TM (E) are labelled
s are the E2gDTM (n ) and E2RVE1TM (h) chimeric forms of E2.proteins is similar to that for the glycoproteins E1 and
p62, encoded by SFV, that interact to form a heteromericcomplex (Ziemiecki et al., 1980). In the absence of p62,
the majority of SFV E1 is in an oligomeric, aggregated
state with very little oxidized protein detected (Anders-
son et al., 1997). By contrast, SFV E1 has a less critical
role in the folding of p62. Thus, it has been suggested
that p62 assists E1 folding through the formation of a
p62/E1 heteromeric complex (Andersson et al., 1997) and
therefore may have a function analogous to that for HCV
E2.
Disrupting the ability of HCV E1 to form intramolecular
disulfide bonds by mutating all of the cysteine residues
does not prevent complex formation with E2 but E2 is
aggregated. Therefore, within aggregates, E1 and E2 can
associate through noncovalent interactions and their in-
teraction need not be stabilized by intermolecular cova-
lent bonds. This agrees with our previous findings in
which the disulfide bonds in aggregated complexes
could be disrupted in cells by DTT, although E1 and E2
continued to associate (Patel et al., 1999). Since native
complexes also are stabilized by noncovalent interac-
tions, this highlights the difficulty with verifying the nature
of E1–E2 complexes that are produced in mammalian
systems that, to date, do not efficiently generate virus
particles. Hence, in the absence of any functional assay
for E1, we employed the existence of nonoligomeric,
oxidized forms of the protein as parameters for authentic
folding.
Based on the above-mentioned parameters, removing
the C-terminal sequences from E2 including the trans-
membrane region reduces but does not prevent associ-
ation with E1. However, the resultant complexes are
aggregated. Fusion of the transmembrane/cytoplasmic
regions from HSV-1 gD and rubella virus E1 to the HCV
E2 ectodomain did not restore native forms of E1 and E2.
This agrees with studies published previously, in which
replacing the E2 transmembrane domain with alternative
FIG. 7. Examination of the behavior of E1 expressed along with gD
fused to the rubella virus E1 transmembrane/cytoplasmic domain. Cells
were electroporated with RNA and radiolabeled, and crude extracts
were subjected to immunoprecipitation using anti-E1 antiserum R528.
Precipitates were examined under nonreducing (lanes 1–3) and reduc-
ing (lanes 4–6) electrophoresis conditions. Samples were pSFV/
E1gDE2TM (lanes 1 and 4), pSFV/E1gDRVE1TM (lanes 2 and 5), and pSFV/E1
(lanes 3 and 6). Positions of aggregated material (Agg), chimeric gD
proteins (gDE2TM and gDRVE1TM), E1, and oligomerized forms of the protein
are indicated.
an
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l., 1994; Michalak et al., 1997; Cocquerel et al., 1998).
The transmembrane/cytoplasmic domain from rubella vi-
rus E1 behaves as an ER retention signal (Hobman et al.,
1997) and thus has similar functional characteristics to
the E2 transmembrane segment. Therefore, retention of
E2 in the ER alone is not sufficient to permit native
complex formation. Significantly, fusion of sequences
containing the E2 transmembrane domain to the ectodo-
main of HSV-1 gD generated complexes in which non-
aggregated gDE2TM chimeric protein could be detected
and E1 was in an oxidized state. Moreover, oligomeriza-
tion of E1 was not detected. Thus, the complex formed by
E1 and gDE2TM has features consistent with those of a
native complex. Processing at the proteolytic site be-
tween E2 and p7 was not necessary for formation of the
complex since identical data could be obtained using a
fragment of E2 that did not contain p7 sequences. There-
fore, our data formally demonstrate that a C-terminal
segment of E2 composed predominantly of the trans-
membrane domain is not only important for E1–E2 com-
plex formation but also critical for correct folding of E1.
As in the case of the interactions between SFV p62
and E1, it has been suggested that E2 has a “chaperone-
like” function to facilitate oxidation and folding of E1
(Michalak et al., 1997). The ability of E1 to oxidize with a
chimeric protein consisting of the HSV-1 gD ectodomain
fused to the E2 transmembrane sequences suggests
that the function of the HCV E2 ectodomain in E1 folding
can be substituted by the equivalent region from a for-
eign glycoprotein. Although it remains possible that there
are specific interactions between E1 and the E2 ectodo-
main, these do not appear to be essential to prevent
aggregation of E1. We propose that interaction between
the E2 transmembrane domain and E1 is a key step in
the folding of E1 but that the role of the ectodomain may
be less specific. It is possible that upon interaction of the
E2 transmembrane domain with E1, the E2 ectodomain
acts as a buffer to prevent association of E1 molecules
within close proximity to each other. Thus, the roles of
the transmembrane and ectodomains of E2 during fold-
ing of E1 are distinct.
Another feature that we observed was the accumula-
tion of incompletely glycosylated forms of E1 if no glyco-
protein was linked downstream of the E1 coding se-
quence (e.g., Fig. 2C, lanes 1 and 2). Appearance of
these species was not dependent on interaction of E1
with its linked partner since they were less apparent on
expression of a polyprotein containing E1 fused to gly-
coproteins with which it did not interact efficiently (see
Fig. 6B, lanes 7 and 12; Fig. 7, lanes 5 and 6). An identical
series of bands corresponding to different E1 glycoforms
also has been identified upon reversing the order of E1
and E2 on the polyprotein (Cocquerel et al., 2000). Similar
to our construct that expressed E1 alone, there were no
sequences beyond the C terminus of the glycoprotein.This possibly suggests that processes at the E1/E2
cleavage site are important for efficient production of
glycosylated E1. Previous studies showed that glycosyl-
ation of E1 at position 325 does not occur as a conse-
quence of a proline residue adjacent to the predicted site
(Meunier et al., 1999). Our data suggest that there may be
additional interactions between E1 and the cellular ma-
chinery, which also are required for efficient glycosyla-
tion at the other sites in E1.
In conclusion, we demonstrated that a short region of
E2 containing the transmembrane domain is essential
for folding of E1 and native complex formation. Attempts
to identify the region in E1 to which the E2 transmem-
brane region binds have not been successful since mu-
tations within the protein result in enhanced aggregation
(data not shown). Additional studies and other ap-
proaches are therefore necessary to examine the se-
quences in E1 that are critical for native complex forma-
tion. Such analysis will shed further light on the com-
plexes formed by the HCV glycoproteins and the
processes involved in virion morphogenesis.
MATERIALS AND METHODS
Cell culture
BHK C13 cells were grown and maintained in Glasgow
minimal Eagle’s medium (GMEM) supplemented with
10% newborn calf serum (NCS), 4% tryptose phosphate
broth, and 100 IU/ml penicillin/streptomycin (ETC10).
Construction of plasmids
A plasmid, pCV-H77c (kindly supplied by J. Bukh), car-
rying the infectious full-length cDNA clone of HCV strain
H77 (Yanagi et al., 1997), provided the DNA fragments for
HCV sequences. The HSV-1 gD coding sequence was
amplified by PCR from a clone, pET28/Bamj, provided by
V. Preston. Details of the regions used in this study to
express E1, E2, and chimeric proteins are given in Fig. 1.
All fragments were initially cloned into vector pGEM-1
(Promega, UK) and then flanked by BglII sites. Recombi-
ant SFV expression vectors were generated by intro-
uction of BglII fragments containing coding sequences
nto the unique BamHI site of pSFV1 (Liljestrom and
Garoff, 1991). pSFV/E1 and pSFV/E12cys were derived
from pSFV/E1E2p7 and pSFV/E12cysE2p7, respectively.
Constructs were made by standard methods using re-
striction enzyme fragments along with synthetic oligonu-
cleotides to combine fragments with incompatible ter-
mini and for mutation of cysteine residues in E1. The E2
transmembrane and HSV-1 gD transmembrane/cytoplas-
mic domain coding sequences were amplified by PCR,
whereas the rubella virus E1 transmembrane/cytoplas-
mic domain sequences were introduced using synthetic
oligonucleotides. The nucleotide sequences of all re-
gions that were modified as a consequence of cloning
procedures were determined before insertion into pSFV1.
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67ROLE OF HCV E2 TRANSMEMBRANE DOMAINIn vitro transcription and electroporation of SFV RNA
into cells
Recombinant pSFV DNAs were linearized with SpeI
nd purified by phenol/chloroform extraction and ethanol
recipitation. After pelleting, DNA was resuspended in
5 ml H2O. In vitro transcription reactions were typically
erformed in a final volume of 50 ml as follows: NTP mix
(1 mM ATP, UTP, CTP, 0.5 mM GTP), transcription buffer
(40 mM Tris, pH 7.9, 6 mM MgCl2, 2 mM spermidine, and
10 mM NaCl), 1 mM m7G(59)ppp(59)G RNA cap analog, 1
mM DTT, 2 units/ml human placental ribonuclease inhib-
itor (RNasin), 2 units/ml SP6 RNA polymerase. A 1.5-mg
sample of linearized template DNA was added to reac-
tions which were incubated at 37°C for 1–2 h.
For electroporation, cells approaching confluency in a
160-cm2 flask were removed by trypsin treatment, resus-
pended in 10 ml ETC10 and pelleted by centrifugation at
400 g for 5 min at room temperature. The cell pellet was
esuspended in 30 ml PBS(A) and pelleted as before.
HK cells were finally resuspended in PBS(A) to a final
oncentration of ;1 3 107 cells/ml. A 0.8-ml aliquot of
resuspended cells was placed in an electroporation cu-
vette (0.4-cm gap; Bio-Rad, Richmond, CA) with 25 ml of
ecombinant pSFV RNA. The cell/RNA suspension was
ixed by inversion and electroporated at 1.2 kV and 25
mF (Bio-Rad Gene Pulser II) at room temperature. The
cells were pulsed twice with an inversion step between
the pulses and then diluted 1/20 in ETC10. Thereafter,
cells were seeded onto 35-mm tissue culture dishes or
13-mm coverslips and incubated at 37°C.
Metabolic labeling of proteins and production of cell
lysates
Medium from cells incubated at 37°C for 4 h postelec-
troporation was replaced with GMEM containing one-
fifth normal concentration of methionine and calf serum
at a final concentration of 2% [GMEM (low met)]. Follow-
ing further incubation at 37°C for 30 min, the medium
was again replaced with GMEM (low met) containing 10
mCi/ml 35S-methionine. Cells were radiolabeled for 12 h
at 37°C before harvesting.
For harvesting, cells were washed twice with 1 ml
ice-cold PBS, containing 20 mM N-ethylmaleimide
(NEM), an alkylating agent that blocks free sulfhydryl
groups on cysteine residues. Cells were lysed using 500
ml of immunoprecipitation buffer (25 mM Tris–HCl, pH
7.5, 300 mM NaCl, 1% Triton X-100, 20 mM NEM, 1 mM
EDTA, 1 mM PMSF). Complete lysis was achieved by
incubation on ice for 10 min and the cell debris was
pelleted by centrifugation at 13,000 g for 10 min at room
temperature.
Deglycosylation of proteinsLysates from cells were denatured in 0.5% (w/v) SDS,
1% (v/v) b-mercaptoethanol at 100°C for 10 min. Sodiumcitrate was added to 50 mM followed by 2000 units of
endo H or 1000 units of PNGase F. For PNGase F diges-
tions 1% (v/v) NP-40 was added to the reaction mix
following the denaturation step to inactivate SDS. The
reactions were incubated at 37°C for 1 h.
Immunoprecipitation of proteins
Cell lysates were incubated at 4°C overnight in 1–5 ml
of the appropriate antibody (diluted 1/500), followed by
addition of 50 ml of equilibrated Protein A–Sepharose
(Sigma, UK) and incubation at 4°C for a further 1 h.
Antibodies used were AP21.010 (an anti-E1 MAb), R528
(an anti-E1 rabbit antiserum), ALP98 (an anti-E2 MAb)
(Patel et al., 1999), and 4846 (an anti-HSV-1 gD MAb) (A.
Cross and H. Marsden, personal communication). E1
and E2 antibodies were raised against purified E1 and
E2 expressed in mammalian cells that were derived from
HCV strain Glasgow (Patel et al., manuscript in prepara-
tion). Immune complexes attached to Sepharose were
pelleted at 1000 g for 30 s and washed three times with
immunoprecipitation buffer. Proteins bound to Sepha-
rose were removed by addition of 200 mM Tris–HCl, pH
6.8, 0.5% SDS, 10% glycerol, and 0.01% bromphenol blue.
Polyacrylamide gel electrophoresis and Western blot
analysis
Samples were prepared for electrophoresis by heating
to 95°C. For electrophoresis under reducing conditions,
DTT was added to samples to a final concentration of 20
mM prior to heating. Cooled samples were electropho-
resed on 10 or 12% polyacrylamide gels cross-linked with
2.5% (w/w) N,N9-methylene bisacrylamide (Laemmli,
1970). Polypeptides were detected by autoradiography
using XS-1 X-ray film (Kodak, Rochester, NY).
For Western blot analysis, proteins were separated on
polyacrylamide gels and transferred to nitrocellulose
membrane (Towbin et al., 1979). After blocking with 5%
milk (Marvel) in PBS, the membrane was incubated with
an E1-specific antiserum (R528; diluted 1/1000) or E2
MAb (ALP98; diluted 1/500) for 4 h in PBS containing 1%
BSA and 0.05% Tween 20. After washing, bound antibody
was detected using a horseradish peroxidase-conju-
gated secondary antibody followed by enhanced chemi-
luminescence (Amersham, UK).
Indirect immunofluorescence
Electroporated cells on coverslips were fixed in meth-
anol and incubated for 20 min at 220°C. Alternatively,
nonpermeabilized cells were prepared by fixing with 4%
paraformaldehyde (PFA; Sigma) for 30 min at 4°C. Per-
meabilized cells were fixed under the same conditions in
PFA containing 0.1% (v/v) Triton X-100. Rehydrated cells
were examined for expression of the protein of interest
using the relevant primary antibody (diluted 1/200) fol-
lowed by visualization using goat anti-mouse (FITC-con-
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68 PATEL, PATEL, AND MCLAUCHLANjugated; Sigma) and goat anti-rabbit (Cy5-conjugated;
Sigma) IgG (diluted 1/100).
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